Skip to content
★ Sign in to follow
SJ
Total declarations
15
Company
1
▲ Purchases (3 ops.)
€48k
▼ Sales (2 ops.)
€30k

Latest filing published 27 Oct 2016 for HAEMONETICS CORP, €103k.

Insider track record

Disclosed buys
3
Disclosed sells
2
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
67%
Median T+90
+2.2%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 02 May 2013 · 4939 days ago · €15k
    -19.2%
    Entry US$38.81 · Close at T+365 US$31.34
  • Filed 05 Nov 2012 · 5117 days ago · €14k
    -3.0%
    Entry US$40.64 · Close at T+365 US$39.43
  • Filed 03 May 2012 · 5303 days ago · €19k
    +8.6%
    Entry US$35.72 · Close at T+365 US$38.81

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Sandra Jesse: trading record in brief

All filings by Sandra Jesse on record concern Haemonetics Corp. We count 15 filings; the first trade dates from 25 October 2011 and the latest from 25 October 2016.

Market trades split into 3 purchases (€48k) and 2 sales (€30k). Taken together, the purchases exceed the sales by €18k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 7 share grants.

A typical purchase (the median) is worth €15k. After 3 purchases with a full 90-day history, the hit rate stands at 67% and the median 90-day move at +2.2%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 27 October 2016, the filings show a share grant worth €103k in Haemonetics Corp. The latest purchase dates back some time: it was published 4,939 days ago, on 2 May 2013. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Sandra Jesse

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◆
    EVP and Chief Legal OfficerExecutivesHaemonetics Corp
    112,482 USD19SEC
    3,288 shares@ US$34.21100.0% of flowCommon StockSEC:0001127602-16-065433:0
  • ◆
    EVP and Chief Legal OfficerExecutivesHaemonetics Corp
    0SEC
    9,765 sharesCommon StockSEC:0001127602-16-037246:0
  • ▼
    EVP and Chief Legal OfficerExecutivesHaemonetics Corp
    24,997 USD0SEC
    778 shares@ US$32.13Common StockSEC:0001127602-15-029704:0
  • ▼
    EVP and Chief Legal OfficerExecutivesHaemonetics Corp
    7,938 USD0SEC
    250 shares@ US$31.75Common StockSEC:0001127602-15-029617:0
  • ◆
    EVP and Chief Legal OfficerExecutivesHaemonetics Corp
    33 USD0SEC
    3,323 shares@ US$0.01Common StockSEC:0001127602-15-029500:0
  • ●
    EVP and Chief Legal OfficerExecutivesHaemonetics Corp
    9,016 USD0SEC
    251 shares@ US$35.92Common StockSEC:0000313143-14-000121:0
  • ●
    EVP and Chief Legal OfficerExecutivesHaemonetics Corp
    9,997 USD0SEC
    276 shares@ US$36.22Common StockSEC:0000313143-14-000121:1
  • ◆
    EVP and Chief Legal OfficerExecutivesHaemonetics Corp
    0SEC
    3,057 shares0Common StockSEC:0000313143-14-000110:0
  • ●
    EVP and Chief Legal OfficerExecutivesHaemonetics Corp
    8,825 USD0SEC
    249 shares@ US$35.44Common StockSEC:0000313143-14-000110:1
  • ◆
    EVP and Chief Legal OfficerExecutivesHaemonetics Corp
    0SEC
    3,060 shares0Common StockSEC:0000313143-13-000174:0
  • ▲
    Chief Legal OfficerExecutivesHaemonetics Corp
    20,096 USD0SEC
    614 shares@ US$32.73Common StockSEC:0000313143-13-000071:0
    Canonical exit: 29 Jul 2013 (T+90)
  • ▲
    VP & CLOExecutivesHaemonetics Corp
    17,516 USD0SEC
    285 shares@ US$61.46Common StockSEC:0000313143-12-000220:0
    Canonical exit: 30 Jan 2013 (T+90)
  • ◆
    VP & CLOExecutivesHaemonetics Corp
    0SEC
    1,536 shares0Common StockSEC:0000313143-12-000176:0
  • ▲
    VP & CLOExecutivesHaemonetics Corp
    24,965 USD0SEC
    501 shares@ US$49.83Common StockSEC:0000313143-12-000046:0
    Canonical exit: 30 Jul 2012 (T+90)
  • ◆
    VP & CLOExecutivesHaemonetics Corp
    17 USD0SEC
    1,711 shares@ US$0.01Common StockSEC:0000313143-11-000082:0

15 of 15 declarations